Viking Therapeutics, Inc.: Truist Securities cuts target price to $85 from $87
VKTX•Truist Securities cut its target price for Viking Therapeutics to $85 from $87.
Related News
Jasper Therapeutics launches cash tender offer to buy back outstanding warrants for $0.324 each
JSPR•
VA selects Clear Secure for pilot to verify veterans signing in to VA.gov
YOU•
Maia Biotech completes enrollment for THIO-101 Phase 2 NSCLC trial of ateganosine plus cemiplimab
MAIA•
Garanti BBVA affirmed at AAA(tr) by JCR Eurasia Rating
BBVA•
Millrose Properties publishes update to financial calendar
MRP•